Issue 8/2019
Content (10 Articles)
Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
- Idiopathic Parkinson Disease
- Leading Article
Daniel Savitt, Joseph Jankovic
Drugs in Development for Acute Kidney Injury
- Acute Kidney Injury
- Leading Article
Matthew Hulse, Mitchell H. Rosner
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
- NSCLC
- Review Article
Sally C. M. Lau, Ullas Batra, Tony S. K. Mok, Herbert H. Loong
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Alopecia
- Review Article
Lydia L. Benitez, Peggy L. Carver
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
- Original Research Article
Aurelie Lenglet, Nicolas Fabresse, Méline Taupin, Cathy Gomila, Sophie Liabeuf, Said Kamel, Jean Claude Alvarez, Tilman B. Drueke, Ziad A. Massy
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy
- Polyneuropathy
- Adis Drug Evaluation
Yvette N. Lamb, Emma D. Deeks
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
- Multiple Sclerosis
- Adis Drug Evaluation
Lesley J. Scott
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
- Open Access
- Acute Lymphoblastic Leukemia
- Correction
Young-A. Heo, Yahiya Y. Syed, Susan J. Keam